GCDH, glutaryl-CoA dehydrogenase, 2639

N. diseases: 72; N. variants: 121
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0013421
Disease: Dystonia
Dystonia
0.430 Biomarker phenotype GENOMICS_ENGLAND Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules. 26316201 2015
CUI: C0013421
Disease: Dystonia
Dystonia
0.430 GeneticVariation phenotype BEFREE We conclude that both GCDH activity and GCDH mutation analysis should be considered in the differential diagnosis of progressive forms of early-onset generalized dystonia and that mitochondrial fatty acid metabolism is one important pathway in the development of dystonia. 21912879 2012
CUI: C0013421
Disease: Dystonia
Dystonia
0.430 Biomarker phenotype BEFREE Glutaryl-CoA dehydrogenase (GCDH) deficiency causes glutaric academia type I (GA-I), an inborn error of metabolism that is characterized clinically by dystonia and dyskinesia and pathologically by neural degeneration of the caudate nucleus and putamen. 15318278 2004
CUI: C0013421
Disease: Dystonia
Dystonia
0.430 Biomarker phenotype BEFREE Glutaryl-CoA dehydrogenase (GCDH) deficiency causes glutaric aciduria type I (GA I), an inborn error of metabolism that is characterized clinically by dystonia and dyskinesia and pathologically by neural degeneration of the caudate and putamen. 10960496 2000
CUI: C0013421
Disease: Dystonia
Dystonia
0.430 Biomarker phenotype GENOMICS_ENGLAND A G-to-T transversion at the +5 position of intron 1 in the glutaryl CoA dehydrogenase gene is associated with the Island Lake variant of glutaric acidemia type I. 7795610 1995
CUI: C0013421
Disease: Dystonia
Dystonia
0.430 Biomarker phenotype HPO
CUI: C0013421
Disease: Dystonia
Dystonia
0.430 Biomarker phenotype GENOMICS_ENGLAND
CUI: C0013421
Disease: Dystonia
Dystonia
0.430 GeneticVariation phenotype CLINVAR